Concepedia

Amanda Siriwardana

AS

3

Publications

463

Citations

3

H-Index

2020

Active since

Affiliations

UNSW Sydney(Current)

The University of Sydney

University of Minnesota Medical Center

Universidade de São Paulo

Concord Repatriation General Hospital

Amanda Siriwardana is an author at UNSW Sydney specializing in glomerulonephritis, medicine, and chronic kidney disease.

ORCID

Top concepts

Publications per year

2020–2023

3

Publications

3

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

, , +9

Impact of Renal Supportive Care on Symptom Burden in Dialysis Patients: A Prospective Observational Cohort Study

Amanda Siriwardana, Anna Hoffman, Frank Brennan et al. · Journal of Pain and Symptom Management · 2020 · 36 citations

, , +14

Rows per page

1–3 of 3